Tocilizumab (Actemra) for giant cell arteritis

Carl W. Bazil, Ericka L. Crouse, Vanessa K. Dalton, Eric J. Epstein, David N. Juurlink, Richard B. Kim, Franco M. Muggia, Sandip K. Mukherjee, Dan M. Roden, Esperance A.K. Schaefer, F. Estelle R. Simons, Neal H. Steigbigel, Arthur M.F. Yee

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)161-162
Number of pages2
JournalMedical Letter on Drugs and Therapeutics
Volume59
Issue number1530
StatePublished - Sep 25 2017

Fingerprint

Giant Cell Arteritis
tocilizumab

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Bazil, C. W., Crouse, E. L., Dalton, V. K., Epstein, E. J., Juurlink, D. N., Kim, R. B., ... Yee, A. M. F. (2017). Tocilizumab (Actemra) for giant cell arteritis. Medical Letter on Drugs and Therapeutics, 59(1530), 161-162.

Tocilizumab (Actemra) for giant cell arteritis. / Bazil, Carl W.; Crouse, Ericka L.; Dalton, Vanessa K.; Epstein, Eric J.; Juurlink, David N.; Kim, Richard B.; Muggia, Franco M.; Mukherjee, Sandip K.; Roden, Dan M.; Schaefer, Esperance A.K.; Simons, F. Estelle R.; Steigbigel, Neal H.; Yee, Arthur M.F.

In: Medical Letter on Drugs and Therapeutics, Vol. 59, No. 1530, 25.09.2017, p. 161-162.

Research output: Contribution to journalComment/debate

Bazil, CW, Crouse, EL, Dalton, VK, Epstein, EJ, Juurlink, DN, Kim, RB, Muggia, FM, Mukherjee, SK, Roden, DM, Schaefer, EAK, Simons, FER, Steigbigel, NH & Yee, AMF 2017, 'Tocilizumab (Actemra) for giant cell arteritis', Medical Letter on Drugs and Therapeutics, vol. 59, no. 1530, pp. 161-162.
Bazil CW, Crouse EL, Dalton VK, Epstein EJ, Juurlink DN, Kim RB et al. Tocilizumab (Actemra) for giant cell arteritis. Medical Letter on Drugs and Therapeutics. 2017 Sep 25;59(1530):161-162.
Bazil, Carl W. ; Crouse, Ericka L. ; Dalton, Vanessa K. ; Epstein, Eric J. ; Juurlink, David N. ; Kim, Richard B. ; Muggia, Franco M. ; Mukherjee, Sandip K. ; Roden, Dan M. ; Schaefer, Esperance A.K. ; Simons, F. Estelle R. ; Steigbigel, Neal H. ; Yee, Arthur M.F. / Tocilizumab (Actemra) for giant cell arteritis. In: Medical Letter on Drugs and Therapeutics. 2017 ; Vol. 59, No. 1530. pp. 161-162.
@article{4abdd37e15394839979c14e2874a79a8,
title = "Tocilizumab (Actemra) for giant cell arteritis",
author = "Bazil, {Carl W.} and Crouse, {Ericka L.} and Dalton, {Vanessa K.} and Epstein, {Eric J.} and Juurlink, {David N.} and Kim, {Richard B.} and Muggia, {Franco M.} and Mukherjee, {Sandip K.} and Roden, {Dan M.} and Schaefer, {Esperance A.K.} and Simons, {F. Estelle R.} and Steigbigel, {Neal H.} and Yee, {Arthur M.F.}",
year = "2017",
month = "9",
day = "25",
language = "English (US)",
volume = "59",
pages = "161--162",
journal = "Medical Letter on Drugs and Therapeutics",
issn = "0025-732X",
publisher = "Medical Letter Inc.",
number = "1530",

}

TY - JOUR

T1 - Tocilizumab (Actemra) for giant cell arteritis

AU - Bazil, Carl W.

AU - Crouse, Ericka L.

AU - Dalton, Vanessa K.

AU - Epstein, Eric J.

AU - Juurlink, David N.

AU - Kim, Richard B.

AU - Muggia, Franco M.

AU - Mukherjee, Sandip K.

AU - Roden, Dan M.

AU - Schaefer, Esperance A.K.

AU - Simons, F. Estelle R.

AU - Steigbigel, Neal H.

AU - Yee, Arthur M.F.

PY - 2017/9/25

Y1 - 2017/9/25

UR - http://www.scopus.com/inward/record.url?scp=85030091048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030091048&partnerID=8YFLogxK

M3 - Comment/debate

VL - 59

SP - 161

EP - 162

JO - Medical Letter on Drugs and Therapeutics

JF - Medical Letter on Drugs and Therapeutics

SN - 0025-732X

IS - 1530

ER -